HUP0301022A2 - Tiotropinium-bromid-monohidrát, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására - Google Patents

Tiotropinium-bromid-monohidrát, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására

Info

Publication number
HUP0301022A2
HUP0301022A2 HU0301022A HUP0301022A HUP0301022A2 HU P0301022 A2 HUP0301022 A2 HU P0301022A2 HU 0301022 A HU0301022 A HU 0301022A HU P0301022 A HUP0301022 A HU P0301022A HU P0301022 A2 HUP0301022 A2 HU P0301022A2
Authority
HU
Hungary
Prior art keywords
production
bromide monohydrate
tiotropium bromide
monohydrate
thiotropininum
Prior art date
Application number
HU0301022A
Other languages
English (en)
Inventor
Rolf Banholzer
Manfred Ludwig August Graulich
Christian Kulinna
Andreas Mathes
Helmut Meissner
Peter Sieger
Peter Specht
Michael Trunk
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0301022(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of HUP0301022A2 publication Critical patent/HUP0301022A2/hu
Publication of HUP0301022A3 publication Critical patent/HUP0301022A3/hu
Publication of HU226830B1 publication Critical patent/HU226830B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány tárgya kristályos tiotropium-bromid-monohidrát, azelőállítására szolgáló eljárás és alkalmazása gyógyszerkészítményelőállítására. A kristályos tiotropium-bromid-monohidrátot úgyállítják elő, hogy a tiotropium-bromidot vízhez adják; az elegyet 50°Cfeletti hőmérsékletre felmelegítve oldják; az oldathoz aktívszenetadnak, és azzal 5-60 percig keverik, majd az aktívszenet szűrésseleltávolítják, és a szűrletből a tiotropium-bromid-monohidrátot lassúlehűtéssel kristályosítják. Az így kapott kristályos monohidrátinhalációs porként olyan megbetegedések kezelésére alkalmazható,amelyekben egy antikolinergikum terápiás hasznot fejthet ki. Ó
HU0301022A 2000-10-12 2001-09-28 Thiotropium bromide monohydrate, method for producing the same and a pharmaceutical composition containing the same HU226830B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050621 2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de) 2000-10-12 2001-09-28 Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (3)

Publication Number Publication Date
HUP0301022A2 true HUP0301022A2 (hu) 2003-10-28
HUP0301022A3 HUP0301022A3 (en) 2005-12-28
HU226830B1 HU226830B1 (en) 2009-11-30

Family

ID=7659568

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301022A HU226830B1 (en) 2000-10-12 2001-09-28 Thiotropium bromide monohydrate, method for producing the same and a pharmaceutical composition containing the same

Country Status (47)

Country Link
EP (2) EP1468998A1 (hu)
JP (1) JP3764422B2 (hu)
KR (1) KR100823860B1 (hu)
CN (2) CN1221549C (hu)
AP (1) AP1572A (hu)
AR (2) AR034389A1 (hu)
AT (1) ATE276253T1 (hu)
AU (2) AU1499602A (hu)
BG (1) BG66161B1 (hu)
BR (1) BR0114584A (hu)
CA (1) CA2425539C (hu)
CR (1) CR6938A (hu)
CZ (1) CZ301841B6 (hu)
DE (1) DE50103666D1 (hu)
DK (1) DK1326862T3 (hu)
DZ (1) DZ3478A1 (hu)
EA (1) EA004381B1 (hu)
EC (1) ECSP034540A (hu)
EE (1) EE04567B1 (hu)
EG (1) EG24142A (hu)
ES (1) ES2228965T3 (hu)
GE (1) GEP20063905B (hu)
HK (2) HK1060567A1 (hu)
HR (1) HRP20030276B1 (hu)
HU (1) HU226830B1 (hu)
IL (2) IL155335A0 (hu)
IS (1) IS2339B (hu)
MA (1) MA25842A1 (hu)
ME (2) MEP40008A (hu)
MX (1) MXPA03003221A (hu)
MY (1) MY126931A (hu)
NO (1) NO328465B1 (hu)
NZ (1) NZ525733A (hu)
OA (1) OA12403A (hu)
PE (1) PE20020422A1 (hu)
PL (1) PL207870B1 (hu)
PT (1) PT1326862E (hu)
RS (1) RS50218B (hu)
SA (1) SA01220412B1 (hu)
SI (1) SI1326862T1 (hu)
SK (1) SK287009B6 (hu)
TR (1) TR200402579T4 (hu)
TW (1) TW589313B (hu)
UA (1) UA74215C2 (hu)
UY (2) UY26962A1 (hu)
WO (1) WO2002030928A1 (hu)
ZA (1) ZA200302500B (hu)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
KR100971616B1 (ko) * 2001-06-22 2010-07-22 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 결정질 항콜린제, 이의 제조방법 및 이를 포함하는 약제학적 조성물
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
WO2005042526A1 (de) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von tiotropiumsalze, tiotropiumsalze sowie arzneimitte lformulierungen diese enthaltend
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
CN1875020B (zh) * 2003-11-03 2010-04-28 贝林格尔.英格海姆国际有限公司 新颖的噻托铵盐,其制备方法及其药物制剂
DE502004010602D1 (de) * 2003-11-03 2010-02-11 Boehringer Ingelheim Pharma Neues kristallines anhydrat mit anticholinerger wirksamkeit
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
PT2422786E (pt) 2004-04-22 2014-11-12 Boehringer Ingelheim Int Novas combinações farmacêuticas para o tratamento de doenças respiratórias
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
JP5566576B2 (ja) * 2004-10-21 2014-08-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器用ブリスタ
CA2600636A1 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
WO2006111549A1 (de) 2005-04-21 2006-10-26 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
AU2006239389B2 (en) 2005-04-28 2012-06-28 Boehringer Ingelheim International Gmbh Novel compounds for treating inflammatory diseases
CA2606549A1 (en) 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
CA2611902C (en) * 2005-06-15 2013-08-27 Boehringer Ingelheim International Gmbh Tiotropium salts, compositions thereof, and processes for preparing same via tiotropium bicarbonate reacted with an acid
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
WO2007017438A1 (en) * 2005-08-06 2007-02-15 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
AU2006281449B2 (en) 2005-08-15 2013-01-31 Boehringer Ingelheim International Gmbh Method for producing betamimetics
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) * 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
JP2008530251A (ja) * 2005-12-19 2008-08-07 シコール インコーポレイティド 純粋且つ安定な臭化チオトロピウム
JP5086267B2 (ja) 2005-12-19 2012-11-28 シコール インコーポレイティド 臭化チオトロピウムの新規な形態およびそれを製造する方法
PT1971332E (pt) * 2006-01-04 2011-03-18 Boehringer Ingelheim Int Utilização de sais de tiotrópio no tratamento da asma moderada persistente
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
NZ585346A (en) 2007-10-19 2011-09-30 Boehringer Ingelheim Int Substituted piperidino-dihydrothienopyrimidines
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20100272811A1 (en) * 2008-07-23 2010-10-28 Alkermes,Inc. Complex of trospium and pharmaceutical compositions thereof
BRPI0923051B1 (pt) 2008-12-19 2022-07-19 Centrexion Therapeutics Corporation Pirimidin-4-carboxamidas cíclicas como antagonistas do receptor de ccr2 para o tratamento de inflamação, asma e copd, seu uso, formulação e combinação farmacêutica que os compreende
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
CN102639531B (zh) 2009-08-07 2016-01-20 基因里克斯(英国)有限公司 噻托溴铵的无水合物
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
KR101530234B1 (ko) 2009-12-17 2015-06-19 베링거 인겔하임 인터내셔날 게엠베하 신규한 ｃｃｒ２ 수용체 길항제 및 이의 용도
US20130143905A1 (en) 2009-12-17 2013-06-06 Boehringer Ingelheim International Gmbh Novel antagonists for ccr2 and uses thereof
EP2528915B1 (en) 2010-01-29 2015-10-28 Boehringer Ingelheim International GmbH Substituted naphthyridines and their use as syk kinase inhibitors
JP5646736B2 (ja) 2010-05-12 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
EP2569298B1 (en) 2010-05-12 2015-11-25 Boehringer Ingelheim International GmbH Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011144501A1 (en) 2010-05-17 2011-11-24 Boehringer Ingelheim International Gmbh Ccr2 antagonists and uses thereof
JP5636094B2 (ja) 2010-05-25 2014-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２受容体アンタゴニスト
JP5721242B2 (ja) 2010-06-01 2015-05-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２アンタゴニスト
JP5959537B2 (ja) 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
JP5786257B2 (ja) 2011-06-16 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の選択的ｃｃｒ２拮抗薬
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
EP2736886B1 (en) 2011-07-26 2016-09-14 Boehringer Ingelheim International GmbH Substituted quinolines and their use as medicaments
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
DK2914593T3 (en) 2012-11-05 2017-04-18 Zentiva Ks STABILIZATION OF TIOTROPIUM SOLVATES
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
ME03472B (me) 2014-03-19 2020-01-20 Boehringer Ingelheim Int Heteroarilni sik inhibitori
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
RU2567539C1 (ru) * 2015-02-04 2015-11-10 Индивидуальный предприниматель Михайлов Олег Ростиславович КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) * 2016-11-04 2018-05-11 Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇ A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CZ284203B6 (cs) * 1992-12-09 1998-09-16 Boehringer Ingelheim Pharmaceuticals Inc. Tekutý aerosolový přípravek obsahující léčivo a způsob stabilisace tohoto prostředku
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
TR200402579T4 (tr) 2004-12-21
BG107687A (bg) 2003-09-30
PE20020422A1 (es) 2002-06-28
EP1468998A1 (de) 2004-10-20
SA01220412B1 (ar) 2006-11-05
NO328465B1 (no) 2010-02-22
EP1326862A1 (de) 2003-07-16
MEP40008A (en) 2011-02-10
SK287009B6 (sk) 2009-09-07
MY126931A (en) 2006-10-31
ES2228965T3 (es) 2005-04-16
CN1469877A (zh) 2004-01-21
HRP20030276B1 (en) 2006-02-28
KR20030042008A (ko) 2003-05-27
AR034389A1 (es) 2004-02-25
MA25842A1 (fr) 2003-07-01
NZ525733A (en) 2005-01-28
AU2002214996B2 (en) 2007-03-15
IL155335A0 (en) 2003-11-23
NO20031694D0 (no) 2003-04-11
UY26962A1 (es) 2002-06-20
YU27303A (sh) 2006-05-25
TW589313B (en) 2004-06-01
CZ301841B6 (cs) 2010-07-07
HRP20030276A2 (en) 2005-02-28
MXPA03003221A (es) 2004-12-03
ECSP034540A (es) 2003-07-25
JP3764422B2 (ja) 2006-04-05
UY34901A (es) 2015-02-27
IL155335A (en) 2009-02-11
SI1326862T1 (en) 2005-02-28
WO2002030928A1 (de) 2002-04-18
AP2003002775A0 (en) 2003-03-31
CA2425539C (en) 2007-04-03
EA200300457A1 (ru) 2003-10-30
GEP20063905B (en) 2006-08-25
NO20031694L (no) 2003-04-11
CN1733761A (zh) 2006-02-15
CA2425539A1 (en) 2003-04-11
EG24142A (en) 2008-08-06
CR6938A (es) 2004-10-28
PT1326862E (pt) 2004-11-30
DZ3478A1 (fr) 2002-04-18
HU226830B1 (en) 2009-11-30
BG66161B1 (bg) 2011-09-30
IS2339B (is) 2008-02-15
AR068527A2 (es) 2009-11-18
AP1572A (en) 2006-02-13
OA12403A (en) 2006-04-18
HUP0301022A3 (en) 2005-12-28
IS6772A (is) 2003-04-09
HK1060567A1 (en) 2004-08-13
AU1499602A (en) 2002-04-22
RS50218B (sr) 2009-07-15
SK4362003A3 (en) 2003-08-05
ME00243B (me) 2011-05-10
CN100519558C (zh) 2009-07-29
KR100823860B1 (ko) 2008-04-21
CN1221549C (zh) 2005-10-05
EE200300171A (et) 2003-06-16
PL207870B1 (pl) 2011-02-28
ATE276253T1 (de) 2004-10-15
HK1086557A1 (en) 2006-09-22
BR0114584A (pt) 2003-08-26
DE50103666D1 (de) 2004-10-21
ZA200302500B (en) 2004-04-22
EP1326862B1 (de) 2004-09-15
JP2004526668A (ja) 2004-09-02
UA74215C2 (uk) 2005-11-15
DK1326862T3 (da) 2004-11-22
EA004381B1 (ru) 2004-04-29
PL366041A1 (en) 2005-01-24
EE04567B1 (et) 2005-12-15

Similar Documents

Publication Publication Date Title
HUP0301022A2 (hu) Tiotropinium-bromid-monohidrát, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására
DE60003025T2 (de) Arylsulfonyle als faktor xa inhibitoren
AU2002359164A8 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer&#39;s disease and conditions associated with glycogen synthase kinase-3
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
HUP0000728A2 (hu) Naftiridinkarbonsavszármazék sója, eljárás előállítására és a vegyületet tartalmazó gyógyászati készítmény
ES8604565A1 (es) Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico
TW200508180A (en) Therapeutic agents
DE60209343D1 (de) Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren
JPH0211546A (ja) ガバペンチン１水化物およびその製法
SE0104334D0 (sv) Therapeutic agents
NO20053748L (no) Pyrrolopyridazinderivater.
MXPA01006474A (es) Derivados colquinol como agentes perjudiciales vasculares.
ATE268179T1 (de) Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung
BRPI0507984B8 (pt) composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamífero, para melhorar a resistência de insulina em um mamífero e para prevenir ou tratar doenças circulatórias em um mamífero, e, uso do composto
HUP0003644A2 (hu) 2,3-Diaril-pirazolo[1,5-b]piridazin-származékok, ezeket tartalmazó gyógyászati készítmények ciklooxigenáz 2(COX-2) gátlására, valamint eljárás a vegyületek előállítására
UA86617C2 (en) 2-(1-AZA-BICYCLO[2.2.2]OCT-3-YL)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4-ONE DERIVATIVES AS LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
HUP0100420A2 (hu) Új makrolidok és előállításuk
NO20061828L (no) Nye derivater av 4A,5,9,10,11,12-heksahydrobenzofuro[3A,3,2][2]-benzazepin, fremgangsmate for fremstilling derav og anvendelse derav ved fremstilling av medikamenter
NO20053809L (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
NO903359D0 (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-9-akridinamin-derivater.
DK1697326T3 (da) Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf
CA2479097A1 (en) Amides of acetic and propionic acids
ATE66913T1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
HUP9700708A2 (hu) N-[(9-pirimido[1,2-a]indolil)-metil-fenil-acetil]-fenil-glicinol-származékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és intermedierjeik

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEG, HU

FH92 Termination of representative

Representative=s name: BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVI, HU